Our multidisciplinary program examines several aspects of placental biology that can influence fetal physiology.
This program includes the following key studies:
- Evaluation of the effects of prenatal exposure to opioids on the placenta including DNA methylation and gene expression
- Examination of COVID-19 biology during pregnancy
- Analysis of how placental disorders impact development to increase the risk of neonatal lung and gut disorders
Explore All Pediatric Research Programs
Our Team
Contact
Principal Investigator
Elizabeth Taglauer
Elizabeth.Taglauer@bmc.org
Investigators
Pictured Below: Principal Investigator Elizabeth Taglauer, MD, PhD investigates the placental origins of neonatal disease.
Research Projects
- Effects of Prenatal Opioid Exposure on Placental DNA Methylation and Gene Expression, March of Dimes Research Grant
- “MASC” Study: Mothers and Infants Affected by Signs and Symptoms of COVID-19, BU CTSI
- “AliGN” Study: Antenatal determinants of Lung and Gut disease in Neonates
- “PRIME” Study: Placental Repository to Improve Infant Outcomes
- POD (Placental Markers of Opioid Use Disorder on Development) Study (R01HD113143)